Table 8 Distribution of resistance phenotypes among US inpatient and outpatient methicillin-resistant Staphylococcus aureus, from 2002 to March 2005 Table 9 Numbers and types of publications arising from Australian Group on Antimicrobial Resistance studies Table 10 Formative enablers and barriers relevant to and options ‘enhance’ ‘construct’ Table 11 A high-level overview of the proposed program, comprising five elements developed over three stages Table 12 Element 1 Surveillance of antimicrobial – resistance Table 13 Element 2 Surveillance of antibiotic usage – Table 14 Element 3 Disease burden and outcomes – Table 15 Element 4 Analysis and action – Table 16 Element 5 Planning – Table 17 Overview of the current status of key elements of the proposed program
Table 8 Distribution of resistance phenotypes among US inpatient and outpatient methicillin-resistant Staphylococcus aureus, from 2002 to March 2005 Table 9 Numbers and types of publications arising from Australian Group on Antimicrobial Resistance studies Table 10 Formative enablers and barriers relevant to ‘enhance’ and ‘construct’ options Table 11 A high-level overview of the proposed program, comprising five elements developed over three stages Table 12 Element 1 – Surveillance of antimicrobial resistance Table 13 Element 2 – Surveillance of antibiotic usage Table 14 Element 3 – Disease burden and outcomes Table 15 Element 4 – Analysis and action Table 16 Element 5 – Planning Table 17 Overview of the current status of key elements of the proposed program
National-surveillance-and-reporting-of-antimicrobial-resistance-and-antibiotic-usage-for-human-health-in-Australia.docx